课题基金 / 基金详情

Nitrogen Containing Natural Products

Nitrogen Containing Natural Products
含氮天然产物
批准号:
6623694
负责人:
STEPHEN MARTIN
金额:
$24.11万
依托单位国家:
美国
项目类别:
财政年份:
1979
资助国家:
美国
项目状态:
已结题
起止时间:
1979-01-01 至 2006-02-28

项目摘要

项目成果

STEPHEN MARTIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (provided by applicant) The objective of this research program is to develop new tactics and strategies to synthesize alkaloid natural products and other biologically-active nitrogen containing compounds. Within this context, there are a number of specific objectives that fall into the two main categories of methodological studies and total synthesis. On the methodological front, the specific goals are to: (1) Explore and develop a novel cascade of reactions involving tandem cyclizations of imines and iminium ions that allows for the rapid, convergent and stereoselective synthesis of fused nitrogen heterocycles; (2) Develop a synthetic method for the homologation of carboxylic acids into alpha, beta-unsaturated ketones; and (3) Develop an efficient, stereoselective procedure for the synthesis of cis-2,5-pyrrolidines having unsaturated substituents. In the arena of total synthesis, the specific goals are to: (1) Apply biogenetically-inspired transformations to the syntheses of the indole alkaloids condylocarpine and akuammidine, an anesthetic agent; (2) Apply ring-closing metathesis as a key step in the concise syntheses of the potent nicotinic acetylcholine receptor agonists anatoxin-a and pinnamine and the anticancer alkaloid peduncularine; (3) Apply a novel, intramolecular variant of the vinylogous Mannich reaction as a key construction in a short synthesis of the potent immunosuppressive agent FR9O1483; (4) Apply cascade imine/iminium ion cyclizations to the concise syntheses of the complex spirocyclic alkaloids halichlorine, a selective inhibitor of the induced vascular cell adhesion molecule-1, and pinnaic acid, a specific inhibitor of cytosolic phospholipase A2 and (5) Submit selected intermediates to Eli Lilly, Merck Research Laboratories, Pfizer, Inc., and Abbott Laboratories for biological evaluation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of positive TMEM97 modulators for treating neuropathic pain
  • 批准号:
    10642506
  • 项目类别:
  • 资助金额:
    $135.22万
  • 财政年份:
    2023
  • 负责人:
    STEPHEN MARTIN
  • 依托单位:
Studies of Molecular Recognition in Biological Systems
  • 批准号:
    7505364
  • 项目类别:
  • 资助金额:
    $28.56万
  • 财政年份:
    2008
  • 负责人:
    STEPHEN MARTIN
  • 依托单位:
Generating Diverse Pilot-Scale Libraries for Screening
  • 批准号:
    7557524
  • 项目类别:
  • 资助金额:
    $35.45万
  • 财政年份:
    2008
  • 负责人:
    STEPHEN MARTIN
  • 依托单位:
Generating Diverse Pilot-Scale Libraries for Screening
  • 批准号:
    7684194
  • 项目类别:
  • 资助金额:
    $35.35万
  • 财政年份:
    2008
  • 负责人:
    STEPHEN MARTIN
  • 依托单位:
国内基金
海外基金
Iboga alkaloids骨架导向的不对称串联反应构建吖庚环并[4,5-b]吲哚及其在全合成中的应用
  • 批准号:
    21801032
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2018
  • 负责人:
    陈惠渝
  • 依托单位: